![]() |
市场调查报告书
商品编码
1899467
乳房X光摄影市场规模、份额和成长分析(按类型、产品类型、技术、应用和地区划分)-2026-2033年产业预测Mammography Market Size, Share, and Growth Analysis, By Type (Screening Mammography, Diagnostic Mammography), By Product (Film Screen Systems, Digital Systems), By Technology, By End Use, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年,乳房X光摄影市场规模将达到 242 万美元,到 2025 年将达到 267 万美元,到 2033 年将达到 576 万美元,在预测期(2026-2033 年)内,复合年增长率为 10.1%。
乳癌发生率的上升以及对早期检测需求的增加,正显着影响乳癌筛检设备市场。随着全球人口的增长,尤其是60岁以上女性(她们占乳癌死亡人数的大多数),有效筛检的需求变得日益迫切。这一年龄层不仅面临更高的发病率和死亡率,也凸显了对先进诊断解决方案的迫切需求。此外,不断涌现的创新乳房X光摄影技术旨在提升使用者体验并提高影像精度。传统的二维乳房X乳房X光摄影由于结构重迭,在影像解读方面存在挑战,而新型系统则有望提供更清晰的影像和更卓越的诊断能力,从而弥补乳癌检测方面的现有不足。
乳房X光摄影市场驱动因素
推动乳房X光摄影市场发展的关键因素是全球乳癌发生率的上升。乳癌是女性最常见的癌症之一,因此早期发现和积极介入的重要性不容忽视。为此,许多医疗机构和政府部门,尤其是在经济发达的国家,正在推行旨在提高公众乳癌意识提升并鼓励定期筛检的筛检计画。这种对早期发现的日益重视,显着提升了对先进乳房筛检技术和服务的需求,最终推动市场发展,并提高了乳房保健服务的可及性和有效性。
乳房X光摄影市场限制因素
乳房X光摄影市场面临许多限制因素,主要源自于先进的数位和3D乳房摄影乳房摄影技术成本高昂。这些技术需要大量的资金投入,而这种经济障碍对发展中地区的小规模医疗机构和设施影响尤为显着,阻碍了它们采用必要的技术。因此,资源有限的地区限制了乳房X光检查技术的普及和市场成长。儘管乳房筛检技术取得了显着进步,但购买和维护这些先进系统的持续成本仍然是市场扩张和提高可及性的重要障碍。
乳房X光摄影市场趋势
将人工智慧 (AI) 应用于乳房筛检流程是目前乳房X光摄影市场的一大趋势。这项转变的驱动力在于提高诊断准确性的需求,因为人工智慧工具能够辅助放射科医生检测出传统评估方法可能遗漏的细微异常。人工智慧辅助乳房X光检查能够更快、更精确地分析乳房X光影像,从而提高早期检出率并最大限度地减少人为误差。随着医疗机构积极采用这项技术,市场将持续发展,整合更先进的人工智慧系统,最终彻底改变乳癌筛检和诊断领域。
Mammography Market size was valued at USD 2.42 Million in 2024 and is poised to grow from USD 2.67 Million in 2025 to USD 5.76 Million by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).
The rising incidence of breast cancer, coupled with a growing demand for early detection, is significantly influencing the market for breast cancer screening devices. As the global population expands, particularly among women aged 60 and older-who represent a substantial percentage of breast cancer fatalities-the necessity for effective screening is becoming increasingly urgent. This demographic not only exhibits high rates of both incidence and mortality but also highlights a pressing need for advanced diagnostic solutions. Furthermore, the continuous introduction of innovative mammography technologies aims to enhance user experience and improve imaging accuracy. While traditional 2D mammography presents challenges in interpreting images due to overlapping structures, newer systems promise clearer imaging and better diagnostic capabilities, addressing the existing gaps in breast cancer detection.
Top-down and bottom-up approaches were used to estimate and validate the size of the Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Mammography Market Segments Analysis
Global Mammography Market is segmented by Type, Product, Technology, End Use and Region. Based on Type, the market is segmented into Screening Mammography, and Diagnostic Mammography. Based on Product, the market is segmented into Film Screen Systems, Digital Systems, Analog Systems, and 3D Systems. Based on Technology, the market is segmented into Breast Tomosynthesis, CAD Mammography, and Digital Mammography. Based on End Use, the market is segmented into Hospitals, Specialty Clinics, Diagnosis Centers, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Mammography Market
A significant factor propelling the growth of the mammography market is the rising prevalence of breast cancer worldwide. As one of the most frequently diagnosed cancers among women, the importance of early detection and proactive measures cannot be overstated. Consequently, numerous healthcare organizations and governmental bodies are implementing screening initiatives to promote breast cancer awareness and encourage regular screenings, particularly in more affluent nations. This heightened focus on early detection has fostered a substantial demand for advanced breast screening technologies and services, ultimately driving the market forward and enhancing the accessibility and effectiveness of breast health management.
Restraints in the Mammography Market
The mammography market faces notable restraints primarily due to the high costs associated with advanced digital breast imaging and 3D breast imaging technologies, which require substantial capital investments. This financial barrier particularly impacts smaller healthcare organizations and facilities in developing regions, hindering their ability to adopt these necessary technologies. As a result, the potential for widespread utilization and market growth is restricted, especially in areas where funding is limited. Despite the significant advancements in breast screening technology, the ongoing expenses related to purchasing and maintaining these sophisticated systems remain a critical obstacle for broader market expansion and accessibility.
Market Trends of the Mammography Market
The mammography market is currently witnessing a significant trend towards the integration of Artificial Intelligence (AI) in breast screening processes. This shift is driven by the need for enhanced diagnostic accuracy, as AI tools assist radiologists in detecting subtle abnormalities that might be missed during traditional evaluations. With AI-assisted mammography, the analysis of mammogram images becomes faster and more precise, thereby improving early detection rates and minimizing the potential for human error. As healthcare providers increasingly adopt this technology, the market is evolving to incorporate advanced AI systems, ultimately transforming the landscape of breast cancer screening and diagnosis.